Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
FDA Approves Idorsia's TRYVIO, First Endothelin Antagonist for Resistant Hypertension
Latest Hotspot
3 min read
FDA Approves Idorsia's TRYVIO, First Endothelin Antagonist for Resistant Hypertension
22 March 2024
The FDA has approved Idorsia's daily drug TRYVIO (aprocitentan), the first to use an endothelin receptor antagonist for managing resistant hypertension alongside other medications.
Read →
The Synapse User's Toolkit: Tips for Searching Propofol
Drug Insights
2 min read
The Synapse User's Toolkit: Tips for Searching Propofol
22 March 2024
Propofol, an agonist of the GABAA receptor, is a small molecule drug primarily used for anesthesia.
Read →
Mabwell's Novel ADC Targets Nectin-4, Shows Promise in Cervical Cancer Treatment
Latest Hotspot
3 min read
Mabwell's Novel ADC Targets Nectin-4, Shows Promise in Cervical Cancer Treatment
22 March 2024
Mabwell's novel antibody-drug conjugate targeting Nectin-4 in cervical cancer shows significant treatment promise according to initial clinical findings.
Read →
What is an Orphan Drug?
"What" Series
2 min read
What is an Orphan Drug?
22 March 2024
An orphan drug is a pharmaceutical product that is developed to treat, diagnose, or prevent rare diseases or conditions.
Read →
Reddy’s Labs introduces Versavo® (bevacizumab) to the UK market
Latest Hotspot
3 min read
Reddy’s Labs introduces Versavo® (bevacizumab) to the UK market
22 March 2024
Dr. Reddy’s Laboratories Ltd., an international enterprise specializing in pharmaceuticals, has officially declared the introduction of its drug Versavo® (bevacizumab) to the UK market.
Read →
Unlock the Power of Synapse: A Guide to Searching Epinephrine
Drug Insights
2 min read
Unlock the Power of Synapse: A Guide to Searching Epinephrine
22 March 2024
Epinephrine, a minute molecule drug, exerts its action as an adrenergic receptor agonist by targeting the adrenergic receptor, exhibiting an extensive list of active indications.
Read →
Orchard Therapeutics Gains FDA Approval for Lenmeldy™ (atidarsagene autotemcel) for Early-Stage Metachromatic Leukodystrophy in Children
Latest Hotspot
3 min read
Orchard Therapeutics Gains FDA Approval for Lenmeldy™ (atidarsagene autotemcel) for Early-Stage Metachromatic Leukodystrophy in Children
22 March 2024
Orchard Therapeutics has obtained U.S. FDA endorsement for Lenmeldy™, a proprietary treatment branded as atidarsagene autotemcel, designed exclusively for young patients diagnosed with early-stage Metachromatic Leukodystrophy.
Read →
What is the meaning of off-label use?
"What" Series
2 min read
What is the meaning of off-label use?
22 March 2024
Off-label use is prescribing or administering a drug in a way not formally sanctioned by regulatory bodies like the FDA or EMA, such as for unapproved conditions, age groups, or dosages.
Read →
Actinium-Based PSMA Radioconjugate Deal Targets Prostate Cancer Treatment and Development
Latest Hotspot
3 min read
Actinium-Based PSMA Radioconjugate Deal Targets Prostate Cancer Treatment and Development
22 March 2024
The deal encompasses a clinical-phase actinium radioconjugate aimed at PSMA to combat prostate cancer, a collection of radioconjugate products in development, and cutting-edge research, development, and production infrastructure.
Read →
How to Effectively Search for Progesterone on Synapse
Drug Insights
2 min read
How to Effectively Search for Progesterone on Synapse
22 March 2024
Progesterone, a diminutive molecule drug, acts as a modulator of the progesterone receptor (PR), exhibiting a broad spectrum of active indications.
Read →
Lynparza and Imfinzi Surpass Chemotherapy in Advanced Endometrial Cancer Response
Latest Hotspot
3 min read
Lynparza and Imfinzi Surpass Chemotherapy in Advanced Endometrial Cancer Response
22 March 2024
Lynparza and Imfinzi substantially increased the average response time, outperforming chemotherapy, in providing clinical advantages for individuals with advanced or relapsed endometrial cancer that shows proficient DNA mismatch repair.
Read →
What Is a Blockbuster Drug?
"What" Series
2 min read
What Is a Blockbuster Drug?
22 March 2024
A "blockbuster drug" is a term used in the pharmaceutical industry to describe a medication that is extremely successful in the market, generating significant sales and revenue.
Read →